(MedPage Today) — The likelihood of treatment-induced hidradenitis suppurativa (HS) varied by more than twofold across different types of biologic therapies for psoriasis, an analysis of a large clinical database showed.
The tumor necrosis factor…
Source link
Risk of Paradoxical Hidradenitis Suppurativa in Psoriasis Varies by Biologic Agent
